Stay updated with breaking news from David Jayne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First orally administered therapy for the treatment of the two main types of ANCA-associated vasculitis approved in Europe First launches expected in H1 2022 Regulatory News: Vifor Fresenius
-- Launch Expected in H1 2022 --
National Robotarium to develop made-to-measure 3D laser beams Researchers at the National Robotarium, hosted by Heriot-Watt University in Edinburgh, have announced that they have secured £586,000 to develop 3D laser beams whose shape can be changed. These 3D lasers could help to transform the manufacturing and healthcare technology industries, making it easier and more cost effective to produce products that require highly-precise manufacturing, such as medical equipment and mobile devices. The funding, which has come from the Engineering and Physical Sciences Resea...
-- Applications for regulatory approval of avacopan in ANCA-associated vasculitis under review in the United States, Europe and Japan; PDUFA goal date of...
ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. ChemoCentryx Inc (NASDAQ: CCXI) Operator Good day and thank you for standing by. Welcome to the ChemoCentryx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the c...